Literature DB >> 2763429

Flunixin pharmacokinetics and serum thromboxane inhibition in the dog.

Q A McKellar1, E A Galbraith, J A Bogan, C S Russell, R E Hooke, P Lees.   

Abstract

Flunixin meglumine administered orally to beagle dogs at doses of 0.55, 1.10 or 1.65 mg/kg bodyweight was rapidly absorbed to produce maximum mean plasma concentrations of 2.40 +/- 0.70, 4.57 +/- 1.12 and 7.42 +/- 2.07 micrograms/ml, respectively. Thereafter, the plasma concentrations of flunixin fell rapidly to values less than 0.10 micrograms/ml from 24 hours after drug administration at all dosage levels. The maximum mean inhibition of serum thromboxane B2 was 91.5 per cent after the lowest dose of flunixin and 98.8 per cent for both the intermediate and high dose rates. At plasma concentrations of flunixin above 2 micrograms/ml there was more than 90 per cent inhibition of thromboxane.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2763429     DOI: 10.1136/vr.124.25.651

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  5 in total

1.  Pharmacokinetics of flunixin after intravenous administration in healthy and endotoxaemic rabbits.

Authors:  M Elmas; E Yazar; K Uney; A Karabacak
Journal:  Vet Res Commun       Date:  2006-01       Impact factor: 2.459

2.  Preliminary pharmacokinetic and pharmacodynamic studies on flunixin meglumine in donkeys.

Authors:  Z Cheng; Q McKellar; A Nolan; P Lees
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

3.  Comparison of in vitro effects of flunixin and tolfenamic acid on human leukocyte and platelet functions.

Authors:  H Kankaanranta; E Moilanen; H Vapaatalo
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

4.  Effects of central and peripheral administration of an acute-phase protein, α-1-acid-glycoprotein, on feed intake and rectal temperature in sheep.

Authors:  Brittany A Gregg; Paxton A Parker; Kathryn M Waller; Liesel G Schneider; Miriam Garcia; Barry Bradford; Joseph A Daniel; Brian K Whitlock
Journal:  J Anim Sci       Date:  2019-12-17       Impact factor: 3.159

5.  Measurement of cyclooxygenase inhibition in vivo: a study of two non-steroidal anti-inflammatory drugs in sheep.

Authors:  Z Cheng; A M Nolan; Q A McKellar
Journal:  Inflammation       Date:  1998-08       Impact factor: 4.092

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.